Health Care & Life Sciences » Biotechnology | Proteon Therapeutics Inc.

Proteon Therapeutics Inc. | Ownership

Companies that own Proteon Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
RA Capital Management LLC
1,337,462
7.57%
0
0.17%
06/30/2018
Deerfield Management Company LP
1,224,899
6.93%
0
0.08%
06/30/2018
Perceptive Advisors LLC
334,116
1.89%
0
0.02%
06/30/2018
Renaissance Technologies LLC
306,481
1.73%
70,381
0%
06/30/2018
Baker Bros. Advisors LP
298,591
1.69%
0
0.01%
06/30/2018
The Vanguard Group, Inc.
143,550
0.81%
-64,524
0%
06/30/2018
Boothbay Fund Management LLC
80,011
0.45%
49,990
0.03%
06/30/2018
DRW Securities LLC
73,686
0.42%
20,000
0.01%
06/30/2018
Financial Counselors, Inc.
50,000
0.28%
0
0%
06/30/2018
DWS Investment GmbH
36,388
0.21%
36,388
0%
06/30/2018

About Proteon Therapeutics

View Profile
Address
200 West Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.proteontherapeutics.com
Updated 07/08/2019
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.